Cellular Biomedicine Group (CBMG) Reports Q2 Loss of $0.52/Share

August 9, 2016 6:29 AM EDT
Get Alerts CBMG Hot Sheet
Trade CBMG Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Cellular Biomedicine Group (NASDAQ: CBMG) reported Q2 EPS of ($0.52), versus ($0.44) reported last year. Revenue for the quarter came in at $71.6 thousand, versus $656.96 thousand reported last year.

For earnings history and earnings-related data on Cellular Biomedicine Group (CBMG) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment